AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Methods For Glycoprotein And Glycopeptide Synthesis

Technology Benefits
New methods for synthesizing bioactive glycoproteins.
Detailed Technology Description
None
Supplementary Information
Patent Number: US7193034B2
Application Number: US2005221199A
Inventor: Bertozzi, Carolyn R.
Priority Date: 23 Sep 1998
Priority Number: US7193034B2
Application Date: 6 Sep 2005
Publication Date: 20 Mar 2007
IPC Current: A61K003800 | C07K000706 | C07K000708 | C07K000900 | C07K001400 | C12N000502
US Class: 530300 | 435325 | 530305 | 530326 | 530327 | 5360186 | 560019 | 514002 | 514012 | 514023 | 514025 | 514052
Assignee Applicant: The Regents of the University of California
Title: Synthetic peptides, conjugation reagents and methods
Usefulness: Synthetic peptides, conjugation reagents and methods
Summary: The compositions are useful for making synthetic peptide conjugates. These peptides may be synthesized in vitro or in vivo and may be incorporated into cells or cellular structures.
Novelty: Synthetic peptides comprising substituted or unsubstituted 2S-amino-levulinic acid residue, for incorporation into peptides e.g. which have therapeutic interest
Industry
Biomedical
Sub Category
DNA/Gene Engineering
Application No.
7193034
Others

Tech ID/UC Case

18598/1999-010-0


Related Cases

1999-010-0

*Abstract

This invention provides methods and compositions useful for making synthetic peptide conjugates. Glycoprotein pharmaceuticals are major targets for the biotechnology industry and include widely used therapeutic agents such as TPA, EPO, and monoclonal antibodies. Glycosylation presents special challenges in drug discovery, development and manufacture due to the heterogeneity of oligosaccharide structures on peptides. New strategies for the production and control of oligosaccharide formation and uniformity would facilitate the development and utility of glycoprotein pharmaceutical agents. This invention relates to the development of novel methods for the synthesis of glycopeptides based on the selective reaction of nucleophilic carbohydrate derivatives with ketone containing peptides. Peptides bearing unnatural ketone side chains can be generated using N-protected (2S)-aminolevulinic acid by solid-phase peptide synthesis (SPPS). Oligosaccharides functionalized at their reducing termini with aminooxy, hydrazide, or thiosemicarbazide groups can be coupled to keto-peptides in aqueous solvent without need for protecting groups or auxiliary coupling reagents. These methods can be used to prepare glycopeptides of therapeutic interest.
References: Marcaurelle, L.A.; Rodriguez, E.C.; Bertozzi, C.R. Synthesis of an oxime-linked neoglycopeptide with glycosylation-dependent activity similar to its native counterpart. Tet. Let.1998.39:8417-8420.
Marcaurelle, L.A.; Bertozzi, C.R. Direct incorporation of unprotected ketone groups into peptides during solid-phase synthesis: Application to the one-step modification of peptides with two different biophysical probes for FRET. Tet. Let.1998.39:7279-7282.

*IP Issue Date
Mar 20, 2007
*Principal Investigator

Name: Carolyn Bertozzi

Department:


Name: LISA MARCAURELL

Department:


Name: ELENA RODRIGUEZ

Department:

Country/Region
USA

For more information, please click Here
Mobile Device